Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-051998
Filing Date
2025-05-22
Accepted
2025-05-22 16:15:16
Documents
1
Period of Report
2025-05-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2515701-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2515701-6_4seq1.xml 4 5041
  Complete submission text file 0001104659-25-051998.txt   6713
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Issuer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INOZYME PHARMA, INC. 321 SUMMER STREET, SUITE 400 BOSTON MA 02210
Business Address
Basso Stephen (Reporting) CIK: 0001815707 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 25977312